5-Bromo-2-(4-methoxyphenyl)pyridine, 95+%, 500mg

3-Amino-4-methyl-2-nitrobenzoic acid, 95.0%, 5g

4,4''-Diamino-p-terphenyl, 95.0%, 5g

N-Benzyl-2-chloro-9-methyl-9H-purin-6-amine, 95+%, 1g

3-[(2-chlorobenzyl)amino]-1-propanol hydrochloride, 95.0%, 250mg

5-Methylcytidine, 98%, 10g

tert-Butyl 1-bromo-5,6,8,9-tetrahydro-7H-imidazo[1,5-d][1,4]diazepine-7-carboxylate, 95%, 500mg

1,3-butandiolo, minimo 99%, per sintesi, 25 l, confezione in plastica.

2-Fluoro-4-(pentafluorosulfur)benzamide, 1g

1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide Hydrochloride [Coupling Agent for Peptides Synthesis]>98.0%(T)250g

Glyoxal 40% soluzione 1L confezione vetro

3-Methoxy-2-nitrobenzamide, 95%, 5g

Methyl 2-(2-chlorophenyl)propanoate, 98%, 100g